Cargando…
Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AOSIS
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244149/ https://www.ncbi.nlm.nih.gov/pubmed/30473877 http://dx.doi.org/10.4102/sajhivmed.v19i1.917 |
| _version_ | 1783372028094447616 |
|---|---|
| author | Moorhouse, Michelle A. Carmona, Sergio Davies, Natasha Dlamini, Sipho van Vuuren, Cloete Manzini, Thandekile Mathe, Moeketsi Moosa, Yunus Nash, Jennifer Nel, Jeremy Pakade, Yoliswa Woods, Joana van Zyl, Gert Conradie, Francesca Venter, Francois Meintjes, Graeme |
| author_facet | Moorhouse, Michelle A. Carmona, Sergio Davies, Natasha Dlamini, Sipho van Vuuren, Cloete Manzini, Thandekile Mathe, Moeketsi Moosa, Yunus Nash, Jennifer Nel, Jeremy Pakade, Yoliswa Woods, Joana van Zyl, Gert Conradie, Francesca Venter, Francois Meintjes, Graeme |
| author_sort | Moorhouse, Michelle A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6244149 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | AOSIS |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62441492018-11-23 Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy Moorhouse, Michelle A. Carmona, Sergio Davies, Natasha Dlamini, Sipho van Vuuren, Cloete Manzini, Thandekile Mathe, Moeketsi Moosa, Yunus Nash, Jennifer Nel, Jeremy Pakade, Yoliswa Woods, Joana van Zyl, Gert Conradie, Francesca Venter, Francois Meintjes, Graeme South Afr J HIV Med Guidelines AOSIS 2018-10-17 /pmc/articles/PMC6244149/ /pubmed/30473877 http://dx.doi.org/10.4102/sajhivmed.v19i1.917 Text en © 2018. The Authors https://creativecommons.org/licenses/by/4.0/ Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. |
| spellingShingle | Guidelines Moorhouse, Michelle A. Carmona, Sergio Davies, Natasha Dlamini, Sipho van Vuuren, Cloete Manzini, Thandekile Mathe, Moeketsi Moosa, Yunus Nash, Jennifer Nel, Jeremy Pakade, Yoliswa Woods, Joana van Zyl, Gert Conradie, Francesca Venter, Francois Meintjes, Graeme Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy |
| title | Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy |
| title_full | Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy |
| title_fullStr | Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy |
| title_full_unstemmed | Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy |
| title_short | Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy |
| title_sort | southern african hiv clinicians society guidance on the use of dolutegravir in first-line antiretroviral therapy |
| topic | Guidelines |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244149/ https://www.ncbi.nlm.nih.gov/pubmed/30473877 http://dx.doi.org/10.4102/sajhivmed.v19i1.917 |
| work_keys_str_mv | AT moorhousemichellea southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT carmonasergio southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT daviesnatasha southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT dlaminisipho southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT vanvuurencloete southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT manzinithandekile southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT mathemoeketsi southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT moosayunus southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT nashjennifer southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT neljeremy southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT pakadeyoliswa southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT woodsjoana southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT vanzylgert southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT conradiefrancesca southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT venterfrancois southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy AT meintjesgraeme southernafricanhivclinicianssocietyguidanceontheuseofdolutegravirinfirstlineantiretroviraltherapy |